Φορτώνει......
A Novel DPYD Variant Associated With Severe Toxicity of Fluoropyrimidines: Role of Pre-emptive DPYD Genotype Screening
Background: The fluoropyrimidine anticancer drug, especially 5- fluorouracil (5-FU) and its prodrug capecitabine are still being the backbone of chemotherapeutic regimens for colorectal cancer. Dihydropyrimidine dehydrogenase (DPD) is the crucial enzyme in the catabolism of 5-FU. Over the past 30 ye...
Αποθηκεύτηκε σε:
Τόπος έκδοσης: | Front Oncol |
---|---|
Κύριοι συγγραφείς: | , , , , |
Μορφή: | Artigo |
Γλώσσα: | Inglês |
Έκδοση: |
Frontiers Media S.A.
2018
|
Θέματα: | |
Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6066555/ https://ncbi.nlm.nih.gov/pubmed/30087856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00279 |
Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|